<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5A51966A-5E02-4F70-A0D3-68077A2C4C03"><gtr:id>5A51966A-5E02-4F70-A0D3-68077A2C4C03</gtr:id><gtr:name>Merck &amp; Co. Inc. (MSD)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Neuroscience Physiology and Pharmacology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5A51966A-5E02-4F70-A0D3-68077A2C4C03"><gtr:id>5A51966A-5E02-4F70-A0D3-68077A2C4C03</gtr:id><gtr:name>Merck &amp; Co. Inc. (MSD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/78132E4B-F641-45DF-A5A9-D1CF2558D7C4"><gtr:id>78132E4B-F641-45DF-A5A9-D1CF2558D7C4</gtr:id><gtr:firstName>Trevor Graeme</gtr:firstName><gtr:surname>Smart</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F4223E4F-3353-4B25-B21D-211488BDE414"><gtr:id>F4223E4F-3353-4B25-B21D-211488BDE414</gtr:id><gtr:firstName>Stuart G</gtr:firstName><gtr:surname>Cull-Candy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4C521556-823A-457B-931F-424427AF13A0"><gtr:id>4C521556-823A-457B-931F-424427AF13A0</gtr:id><gtr:firstName>stephen</gtr:firstName><gtr:surname>Moss</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A544B3F6-A07A-498E-9B7D-31D055013F58"><gtr:id>A544B3F6-A07A-498E-9B7D-31D055013F58</gtr:id><gtr:firstName>Annette</gtr:firstName><gtr:otherNames>Catherine</gtr:otherNames><gtr:surname>Dolphin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G9722520"><gtr:id>EA4AB7A5-16CF-4436-8C00-4550E92A6534</gtr:id><gtr:title>Molecular and cellular studies of synaptic receptors and ion channels</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9722520</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1998-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>139143</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck &amp; Co. Inc. (MSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mechanism of action of THIP</gtr:description><gtr:id>9F1B3986-7566-4C73-B099-A7DC1F049E26</gtr:id><gtr:impact>We have deduced at the molecular level how THiP activates GABA receptors. This drug was developed as a hypnotic and reached phase II trials. We have a publication currently under revision</gtr:impact><gtr:partnerContribution>Provision of resources to study the action of this hypnotic</gtr:partnerContribution><gtr:piContribution>We used multi-disciplinary approaches to exactly determine how THIP acts at the GABA-A receptor deriving new infomation about how GABA-A receptors are activated.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>UCL Institute Structural and Molecular Biology retreat, Keynote lecture: Molecular regulation of the GABAA receptor.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>30AD6407-BE41-4821-B017-B763F9C99A67</gtr:id><gtr:impact>Plenary lecture

Recognition by peers</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Neuroscience and Pharmacology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>72207E5C-7074-4F69-A674-73EE76DB5CF0</gtr:id><gtr:impact>&amp;gt;100 pupils attended a careers talk and demonstration of the outreach of science

Sixth form and work experience applications made to the college</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Distinguished Gowdey Lecture</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E9B3AF83-80DD-4096-9EE8-2AF16DC2A371</gtr:id><gtr:impact>Prize lecture on GABA-A receptors, basic science and clinical

Recognition by peers</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Max Planck symposium Ringberg Castle, Munich: Intercellular communication in the nervous system, from development to roles in health and disease. Keynote Lecture: Structure-function studies on inhibitory amino acid receptors.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D0DD1CB4-FBAA-463E-B76F-193AE7B97B98</gtr:id><gtr:impact>Plenary lecture

Recognition by peers</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Max Planck symposium Ringberg Castle, Munich: Intercellular communication in the nervous system, from development to roles in health and disease. Keynote Lecture: Structure-function studies on inhibitory amino acid receptors.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F2DD2E73-C077-4684-885A-FAD782E117E9</gtr:id><gtr:impact>Keynote lecture

none so far</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kyoto symposium on Mechanisms of GABAergic Synaptic Transmission, Japanese Neuroscience Society meeting. Autocrine mGluR1 activation in cerebellar Purkinje cells regulates GABA-mediated synaptic inhibition.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>96B9C328-B4D1-4278-A4F3-772673AE2308</gtr:id><gtr:impact>Plenary lecture

Representing UK neuroscience</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>9th Winter Brain Conference, Solden, Austria: Electrophysiological approaches to study membrane dynamics of GABAA receptors in the brain.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C34C550A-FCF1-4945-8D54-AC90ACC8274C</gtr:id><gtr:impact>Plenary lecture

Recognition by peers</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Paris, CNRS: Molecular regulation of the GABAA receptor.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1722A11E-539D-4AB9-970A-20325BDB10BB</gtr:id><gtr:impact>Lecture to academics &amp;amp; students

Recognition by peers, collaborative research links established</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>9th Winter Brain Conference, Solden, Austria: Electrophysiological approaches to study membrane dynamics of GABAA receptors in the brain.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BCA10F94-5860-4024-A6E9-D447094C5A38</gtr:id><gtr:impact>Research seminar to academics

None so far</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Clinical Sciences Centre, Imperial College London:</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>487BC24D-015C-474B-BEF3-2B725A7F4C2B</gtr:id><gtr:impact>Lecture to academics &amp;amp; students

Highlighting pharmacological approaches to CNS study</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Showcase Symposium, Neuroscience and Mental Health Board.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CB5CFDA8-3CC1-408C-AEA5-78A86DC605D0</gtr:id><gtr:impact>Lecture to academics, clinicians &amp;amp; students, policy makers

part of MRC showcase</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Eisai, UCL. The Inhibitory Synapse.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B5C10E9F-552A-45E8-88D6-102A8BB266AB</gtr:id><gtr:impact>Seminar to acadmics &amp;amp; industrialists

Part of Eisai scientific advisory board</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scottish Neuroscience meeting: Plenary Keynote Lecture:</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F8BA2F1F-6D2E-41FE-9985-A485BF188AE5</gtr:id><gtr:impact>Plenary keynote lecture

Recognition by peers</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>3200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G9722520</gtr:fundingRef><gtr:id>E882440C-DE41-4A41-8A53-539808DF0D6E</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D508F5CE-A5AB-4FA0-99E3-4B78A447B8B1"><gtr:id>D508F5CE-A5AB-4FA0-99E3-4B78A447B8B1</gtr:id><gtr:title>HEK293 cell line: a vehicle for the expression of recombinant proteins.</gtr:title><gtr:parentPublicationTitle>Journal of pharmacological and toxicological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a743390220adf77fab7bcb8de2d5452"><gtr:id>4a743390220adf77fab7bcb8de2d5452</gtr:id><gtr:otherNames>Thomas P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1056-8719</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/28167766-0C22-45EB-972F-4873DD3542EB"><gtr:id>28167766-0C22-45EB-972F-4873DD3542EB</gtr:id><gtr:title>The Concise Guide to PHARMACOLOGY 2013/14: overview.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/22eb2c18ba534f4f36ee595a2e355c9a"><gtr:id>22eb2c18ba534f4f36ee595a2e355c9a</gtr:id><gtr:otherNames>Alexander SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/54CA52FE-5425-4E72-B5F2-C95C0521D647"><gtr:id>54CA52FE-5425-4E72-B5F2-C95C0521D647</gtr:id><gtr:title>Molecular determinants of glycine receptor alphabeta subunit sensitivities to Zn2+-mediated inhibition.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5d4baceaf0e34aa81cd387370317059"><gtr:id>e5d4baceaf0e34aa81cd387370317059</gtr:id><gtr:otherNames>Miller PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C35EACDD-1CCC-4C9F-B539-4FA21221EAED"><gtr:id>C35EACDD-1CCC-4C9F-B539-4FA21221EAED</gtr:id><gtr:title>Molecular basis for zinc potentiation at strychnine-sensitive glycine receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e5d4baceaf0e34aa81cd387370317059"><gtr:id>e5d4baceaf0e34aa81cd387370317059</gtr:id><gtr:otherNames>Miller PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9722520</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>